Investigations

$38,398 for a Single Shot of a Very Old Cancer Drug

Lupron, a drug patented half a century ago, treats advanced prostate cancer. It’s sold to physicians for $260 in the U.K. and administered at no charge. Why are U.S. hospitals — which may pay nearly as little for the drug — charging so much more to administer it?

Listen: Grieving Families Face the Cruelest Bills

KHN Midwest correspondent Lauren Weber talks with NPR’s “Consider This” podcast about her reporting on families confronted with medical bills while grieving the loss of a baby who received expensive hospital care.